NCT01365208View on ClinicalTrials.gov

New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

March 3, 2017

Study Completion Date

March 3, 2017

Conditions
Advanced Nasopharyngeal Carcinoma
Interventions
DRUG

Chemotherapy

platinum-based chemotherapy

Trial Locations (1)

Unknown

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT01365208 - New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer | Biotech Hunter | Biotech Hunter